TC Biopharm (NASDAQ:TCBP) Trading Down 2%

TC Biopharm (Holdings) Plc (NASDAQ:TCBP)’s share price fell 2% during mid-day trading on Thursday . The stock traded as low as $1.43 and last traded at $1.45. 44,352 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 3,492,144 shares. The stock had previously closed at $1.48.

TC Biopharm Price Performance

The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.20 and a current ratio of 1.20. The business has a 50 day simple moving average of $1.48 and a 200-day simple moving average of $13.42.

TC Biopharm Company Profile

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers.